In the age of decentralized clinical trials (DCTs), an all-or-nothing approach is not usually practical. Some research participants prefer to speak to study staff in person, and may find that remote technology doesn’t establish the trust they need to enroll. Accommodating patient preference requires a hybrid eConsent model which allows for remote and on-site enrollment.

Register for this webinar, where thought leaders from Castor and Lightship discuss opportunities that will help researchers develop a more successful overall strategy for their patient enrollment. From eRecruitment, pre-screening and consent, we’ll discuss how anticipating and accommodating patient preferences streamlines enrollment and increases retention.

In this webinar, participants will learn about:

Making patient preference easy in the enrollment process
eConsent challenges and solutions
Steps to consider when implementing hybrid eConsent
An end-to-end eConsent solution for recruitment, pre-screening, and remote consent

Keywords:

Speakers

Sam Eells, Co-Founder and Chief Design Officer, Lightship

Sam Eells is the Co-Founder and Chief Design Officer at Lightship, the virtual-first clinical trial provider creating access for all patients. She is a vision-driven executive with a background in epidemiology and over 10 years of experience conducting high-quality clinical research within start-up and academic environments, including the Los Angeles Biomedical Research Institute and UCLA.

Throughout her career, Sam worked with non-insured patients to prevent infections in their communities and to give them better protection. At Lightship, Sam is scaling these efforts by providing access to clinical trials and treatment to underserved populations, especially those that find access to public health difficult.

Focused on the best patient experience and dedicated to operational excellence built on performance and integrity, Sam works to transform how patients access and take part in clinical studies.

Message Presenter

Derk Arts, M.D., Founder and CEO of Castor

Derk Arts MD, PhD has over fifteen years of experience in medicine, research and technology. He founded Castor to solve the biggest issues in clinical research: a lack of inclusivity, patient focus and impact of data. Castor enables sponsors worldwide to run patient-centric trials on a unified platform, that helps them maximize the impact of research data on patient lives.

Dr. Derk Arts believes the key to achieving lasting change in the industry is through scalability and standardization. Technology to run better trials and maximize the impact of data should be available to all researchers.

Over the past 12 months, Castor provided pro-bono support to over 300 COVID-19 trials, and provided the entire infrastructure for the World Health Organizations’ Solidarity Trials.

Message Presenter

Jennifer Arters, Patient

“Participating in clinical trials not only brings me hope that we can find a cure, but also to educate others about how clinical trials bring lifesaving medicines to market. With my experiences, I am fortunate to tell my story from a patients perspective to help make clinical trials a great experience for those willing to donate their body to science for the greater good.”

Message Presenter

Who Should Attend?

Senior professionals who are in:

Clinical Operations
Clinical Data Managers
Clinical Project Managers
Study Managers
Clinical Research
Research and Development
Scientific Affairs

What You Will Learn

In this webinar, participants will learn about:

Making patient preference easy in the enrollment process
eConsent Challenges
Steps to consider when implementing a hybrid eConsent
An end-to-end eConsent solution for recruitment, pre-screening and consent

Xtalks Partners

Castor

Castor is a leading provider of decentralized and hybrid clinical trial solutions to democratize research. With the highest rated eClinical platform for decentralized and hybrid clinical trials, Castor’s plug and play platform offers rapid deployment at scale, enabling researchers to create a trial in a matter of clicks, with easy enrollment, consent and real-world data capture. Castor is bringing human-centered design to the clinical trial process, from recruitment to analysis, and improving the quality, security and reusability of data for researchers worldwide. For more information, visit www.castoredc.com.

Lightship

Lightship is the virtual-first provider that is perfecting the way clinical trials get done. Because clinical research plays such a vital role in bringing life-enhancing and life-saving innovations to market, Lightship pursues operational excellence in clinical studies. Our end-to-end delivery model, our diversity of skill sets, and in-house care team ensure sponsor success and the best possible patient experience. Learn more about us at www.lightship.com.